» Articles » PMID: 1850037

Mutations in the Regions of the Rous Sarcoma Virus 3' Splice Sites: Implications for Regulation of Alternative Splicing

Overview
Journal J Virol
Date 1991 May 1
PMID 1850037
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Retrovirus RNA is synthesized as a single primary transcript that is differentially processed by RNA splicing. Three species of viral RNA (spliced env, spliced src, and unspliced full-length RNA) are produced in chicken embryo fibroblasts infected with Rous sarcoma virus, an avian retrovirus. The env and src mRNAs are synthesized by the alternative use of two 3' splice sites. The mechanism by which balanced splicing at the two sites is maintained was investigated in this report. Mutants that increase or decrease splicing at one of the two 3' splice sites were analyzed for the effect on splicing at the other site. The two splice sites differed in their response. Mutations that caused a specific increase in the level of spliced env mRNA were associated with reciprocal changes in the levels of src mRNA but with no change in overall splicing. In contrast, mutants in which the src 3' splice site was inactivated demonstrated a decreased overall level of spliced RNA but had little or no effect on the level of spliced env mRNA. Mutations that caused specific increases in the level of spliced src mRNA had variable effects on env mRNA levels. Deletion of regions in gag, which was previously shown to contain a cis-acting negative regulator of splicing, resulted in a corresponding increase of both spliced viral mRNAs and a decrease in unspliced RNA, suggesting that this element suppressed both env and src splicing. Several models are discussed which are possible mechanisms for regulation of alternative splicing of Rous sarcoma virus RNA, but none of these models appear to be consistent with all of the data.

Citing Articles

Evidence that a threshold of serine/arginine-rich (SR) proteins recruits CFIm to promote rous sarcoma virus mRNA 3' end formation.

Hudson S, McNally L, McNally M Virology. 2016; 498:181-191.

PMID: 27596537 PMC: 5045808. DOI: 10.1016/j.virol.2016.08.021.


Juxtaposition of two distant, serine-arginine-rich protein-binding elements is required for optimal polyadenylation in Rous sarcoma virus.

Hudson S, McNally M J Virol. 2011; 85(21):11351-60.

PMID: 21849435 PMC: 3194969. DOI: 10.1128/JVI.00721-11.


RNA processing control in avian retroviruses.

McNally M Front Biosci. 2008; 13:3869-83.

PMID: 18508481 PMC: 2575692. DOI: 10.2741/2975.


Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site.

Verhoef K, Bilodeau P, van Wamel J, Kjems J, Stoltzfus C, Berkhout B J Virol. 2001; 75(7):3495-500.

PMID: 11238879 PMC: 114146. DOI: 10.1128/JVI.75.7.3495-3500.2001.


U1 small nuclear ribonucleoprotein and splicing inhibition by the rous sarcoma virus negative regulator of splicing element.

McNally L, McNally M J Virol. 1999; 73(3):2385-93.

PMID: 9971822 PMC: 104484. DOI: 10.1128/JVI.73.3.2385-2393.1999.


References
1.
Sharp P . Splicing of messenger RNA precursors. Science. 1987; 235(4790):766-71. DOI: 10.1126/science.3544217. View

2.
Strohman R, Moss P, Spector D, Przybyla A, Paterson B . Messenger RNA for myosin polypeptides: isolation from single myogenic cell cultures. Cell. 1977; 10(2):265-73. DOI: 10.1016/0092-8674(77)90220-3. View

3.
KATZ R, Skalka A . Control of retroviral RNA splicing through maintenance of suboptimal processing signals. Mol Cell Biol. 1990; 10(2):696-704. PMC: 360868. DOI: 10.1128/mcb.10.2.696-704.1990. View

4.
Swanstrom R, Parker R, Varmus H, Bishop J . Transduction of a cellular oncogene: the genesis of Rous sarcoma virus. Proc Natl Acad Sci U S A. 1983; 80(9):2519-23. PMC: 393857. DOI: 10.1073/pnas.80.9.2519. View

5.
Ficht T, Chang L, Stoltzfus C . Avian sarcoma virus gag and env gene structural protein precursors contain a common amino-terminal sequence. Proc Natl Acad Sci U S A. 1984; 81(2):362-6. PMC: 344676. DOI: 10.1073/pnas.81.2.362. View